Physician profile
Samir Patel
NPI 1124058698
$45,723.56
in general payments reported to CMS, 2019-2025
16 companies · $1,206 in 2025
The $1,206 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,841 · 2020: $4,179 · 2021: $2,695 · 2022: $17K · 2023: $17K · 2024: $2,420 · 2025: $1,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $5,034 · Travel and Lodging: $2,060 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Gift: $49.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,019.47 |
| Food and Beverage | $5,033.51 |
| Travel and Lodging | $2,060.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Gift | $49.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $37,597.14 | 2020-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Ethicon US, LLC | $2,331.68 | 2019-2025 | Enseal, Ethicon, Echelon Endopath |
| W. L. Gore & Associates, INC. | $2,289.24 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Seamguard Staple Line Reinforcement |
| Medical Device Business Services, INC. | $1,248.01 | 2023 | Linx Reflux Management System |
| Medtronic, INC. | $864.82 | 2022-2025 | Endoflip, Signia |
| Cook Medical LLC | $660.77 | 2019 | |
| Novo Nordisk INC | $301.56 | 2019-2025 | Wegovy |
| Stryker Corporation | $134.15 | 2019 | |
| Lilly USA, LLC | $87.77 | 2024-2025 | Zepbound, Mounjaro |
| Boston Scientific Corporation | $72.27 | 2025 | Spyglass Discover |
| Karl Storz Endoscopy-America | $34.19 | 2021 | |
| Davol INC. | $27.39 | 2021 | |
| Phathom Pharmaceuticals, INC. | $24.71 | 2024-2025 | Voquezna |
| Abbvie INC. | $21.67 | 2023 | |
| Glaxosmithkline, LLC. | $14.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.